BioSpace News Archive

The main purpose of radiology information systems (RIS) is to manage medical imagery and associated data.

NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that Mathias Oelke, Ph.D., has been promoted to Chief Scientific Officer.

Angion Biomedica Corp., a biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, announced participation in an upcoming investment conference.

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to twenty-eight new employees.

Illumina, Inc. (NASDAQ: ILMN) today announced that it will issue results for the first quarter 2022 following the close of market on Thursday, May 5, 2022.

Pasithea Therapeutics Corp. announced its Chief Executive Officer, Tiago Reis Marques, will present at NobleCon18 - Noble Capital Markets’ Eighteenth Annual Investor Conference in Hollywood, FL, as follows:

Biohaven Pharmaceutical Holding Company Ltd. announced the publication of new real-world research showing that as migraine-related disability increases, healthcare utilization also increases among Americans with episodic migraine.

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.38 per share.

An unusual X-linked lysosomal storage condition is known as fabry disease. In this patient suffers from lack of alpha galactosidase enzyme that leads to progressive organ dysfunction.

Albany NY, United States: Hypereosinophilic syndrome is associated with a very high count of eosinophil in the blood.